Results 231 to 240 of about 17,021,466 (309)
Disparities in hepatitis C among people aged 12-59 with no history of injection drug use, United States, January 2013-March 2020. [PDF]
Ly KN +5 more
europepmc +1 more source
Rapid thiol‐maleimide addition frequently outpaces mixing, resulting in heterogeneous hydrogels. S‐nitrosothiols act as thiol‐protecting groups, allowing uniform mixing with maleimide‐functionalized polymers before gelation. Sodium thiosulfate or sodium ascorbate then regenerates thiols on demand, triggering controlled thiol‐maleimide crosslinking ...
Julian A. Serna +7 more
wiley +1 more source
Non-injection drug use among incarcerated people in Iran: Findings from three consecutive national bio-behavioral surveys. [PDF]
Rafiee M +7 more
europepmc +1 more source
Soft Yet Tough Tanglemers Through Rapid Photopolymerization for DLP 3D Printing
Soft yet tough tanglemers are produced through low‐initiator free radical photopolymerization and translated to DLP 3D printing. Systematic control over light intensity, initiator loading, and crosslink density reveals processing windows that balance printability, elasticity, toughness, and feature fidelity. ABSTRACT Additive manufacturing of compliant
Yutong Liu +5 more
wiley +1 more source
Association between non-injection drug use and hepatitis C infection among HIV-negative men who have sex with men. [PDF]
Zhao J +5 more
europepmc +1 more source
Alkoxy chain length drives a continuous transition from eclipsed AA to a serrated, slipped AA* configuration over Co‐porphyrin COFs. A moderate slip both contracts the pore channel to enrich CO2 and suppress hydrogen evolution, and enhances collective high‐spin of Co sites, which delivers a record CO production rate with high selectivity.
Jie He +8 more
wiley +1 more source
Correction: Non-injection drug use among incarcerated people in Iran: Findings from three consecutive national bio-behavioral surveys. [PDF]
Rafiee M +7 more
europepmc +1 more source
Advanced Materials for Biologics Delivery to Brain Tumors
Material innovation is central to unlocking the therapeutic potential of biologics against many central nervous system diseases, including brain cancer. By engineering carriers with controlled transport, targeting, and release properties, advanced materials can overcome the blood–brain barrier and tumor microenvironment, improving the delivery of ...
Yuran Feng +4 more
wiley +1 more source
A cholesterol‐conjugated lipid library enabled the identification of a ligand‐free LNP platform for efficient mRNA delivery to brain endothelial cells via systemic administration. This platform achieves selective BBB targeting without disrupting barrier integrity, and enables modulation of neuroinflammation and vascular function without requiring trans‐
Zeru Tian +7 more
wiley +1 more source

